HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right

Reuters08-04

HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right

HilleVax, Inc. and XOMA Royalty Corporation have announced a definitive merger agreement, under which XOMA Royalty will acquire all outstanding shares of HilleVax common stock. The transaction involves a cash payment of $1.95 per share plus a contingent value right. The tender offer to acquire HilleVax shares is expected to commence by August 18, 2025, with the acquisition anticipated to close in September 2025. Approximately 22.9% of HilleVax shareholders, including certain officers, directors, and stockholders, have agreed to support the merger by tendering their shares. The announcement was made by both companies, with Leerink Partners and Latham & Watkins LLP advising HilleVax, and Gibson, Dunn & Crutcher LLP advising XOMA Royalty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hillevax Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9505302-en) on August 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2556638340?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-04 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556638340","market":"nz","top_or_hot":-1,"title":"HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/HLVX\">HilleVax, Inc.</a> and XOMA Royalty Corporation have announced a definitive merger agreement, under which XOMA Royalty will acquire all outstanding shares of HilleVax common stock. The transaction involves a cash payment of $1.95 per share plus a contingent value right. The tender offer to acquire HilleVax shares is expected to commence by August 18, 2025, with the acquisition anticipated to close in September 2025. Approximately 22.9% of HilleVax shareholders, including certain officers, directors, and stockholders, have agreed to support the merger by tendering their shares. The announcement was made by both companies, with Leerink Partners and Latham &amp; Watkins LLP advising HilleVax, and Gibson, Dunn &amp; Crutcher LLP advising XOMA Royalty.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hillevax Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9505302-en) on August 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-04 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/HLVX\">HilleVax, Inc.</a> and XOMA Royalty Corporation have announced a definitive merger agreement, under which XOMA Royalty will acquire all outstanding shares of HilleVax common stock. The transaction involves a cash payment of $1.95 per share plus a contingent value right. The tender offer to acquire HilleVax shares is expected to commence by August 18, 2025, with the acquisition anticipated to close in September 2025. Approximately 22.9% of HilleVax shareholders, including certain officers, directors, and stockholders, have agreed to support the merger by tendering their shares. The announcement was made by both companies, with Leerink Partners and Latham &amp; Watkins LLP advising HilleVax, and Gibson, Dunn &amp; Crutcher LLP advising XOMA Royalty.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hillevax Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9505302-en) on August 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2210150020.SGD","symbol_name":"Natixis Thematics Subscription Economy R/A SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDLbY1qHY:1","article_id":"2556638340","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556638340","pubTimestamp":1754305256,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"HilleVax, Inc. and XOMA Royalty Corporation have announced a definitive merger agreement, under which XOMA Royalty will acquire all outstanding shares of HilleVax common stock. The transaction involves a cash payment of $1.95 per share plus a contingent value right. The tender offer to acquire HilleVax shares is expected to commence by August 18, 2025, with the acquisition anticipated to close in September 2025. Approximately 22.9% of HilleVax shareholders, including certain officers, directors, and stockholders, have agreed to support the merger by tendering their shares. The announcement was made by both companies, with Leerink Partners and Latham & Watkins LLP advising HilleVax, and Gibson, Dunn & Crutcher LLP advising XOMA Royalty.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4588":"碎股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC","BK4139":"生物科技","BK4585":"ETF&股票定投概念","HLVX":"HilleVax, Inc.","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","XOMA":"标记临床研究","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","NDAQ":"纳斯达克OMX交易所","BK4112":"金融交易所和数据"},"translate_title":"HilleVax Inc.宣布同意被XOMA Royalty以每股1.95美元外加或有价值权收购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XOMA":0.9,"NDAQ":0.9,"HLVX":0.9},"content_text":"HilleVax Inc. Announces Agreement to Be Acquired by XOMA Royalty for $1.95 Per Share Plus Contingent Value Right\n    \n\nHilleVax, Inc. and XOMA Royalty Corporation have announced a definitive merger agreement, under which XOMA Royalty will acquire all outstanding shares of HilleVax common stock. The transaction involves a cash payment of $1.95 per share plus a contingent value right. The tender offer to acquire HilleVax shares is expected to commence by August 18, 2025, with the acquisition anticipated to close in September 2025. Approximately 22.9% of HilleVax shareholders, including certain officers, directors, and stockholders, have agreed to support the merger by tendering their shares. The announcement was made by both companies, with Leerink Partners and Latham & Watkins LLP advising HilleVax, and Gibson, Dunn & Crutcher LLP advising XOMA Royalty.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hillevax Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9505302-en) on August 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556638340","isCrawlerRequest":true}